These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
114 related items for PubMed ID: 39024474
1. Schisandrin B restores M1/M2 balance through miR-124 in lipopolysaccharide-induced BV2 cells. Yang Y, Liu R, Sun Y, Wu B, He B, Jia Y, Yan T. J Pharm Pharmacol; 2024 Oct 03; 76(10):1352-1361. PubMed ID: 39024474 [Abstract] [Full Text] [Related]
2. Polysaccharide from Schisandra chinensis acts via LRP-1 to reverse microglia activation through suppression of the NF-κB and MAPK signaling. Xu M, Wang J, Zhang X, Yan T, Wu B, Bi K, Jia Y. J Ethnopharmacol; 2020 Jun 28; 256():112798. PubMed ID: 32251761 [Abstract] [Full Text] [Related]
3. Schisandrin B exerts anti-neuroinflammatory activity by inhibiting the Toll-like receptor 4-dependent MyD88/IKK/NF-κB signaling pathway in lipopolysaccharide-induced microglia. Zeng KW, Zhang T, Fu H, Liu GX, Wang XM. Eur J Pharmacol; 2012 Oct 05; 692(1-3):29-37. PubMed ID: 22698579 [Abstract] [Full Text] [Related]
4. Curcumin inhibits LPS-induced neuroinflammation by promoting microglial M2 polarization via TREM2/ TLR4/ NF-κB pathways in BV2 cells. Zhang J, Zheng Y, Luo Y, Du Y, Zhang X, Fu J. Mol Immunol; 2019 Dec 05; 116():29-37. PubMed ID: 31590042 [Abstract] [Full Text] [Related]
5. Schisandrin B inhibits LPS-induced inflammatory response in human umbilical vein endothelial cells by activating Nrf2. Lin Q, Qin X, Shi M, Qin Z, Meng Y, Qin Z, Guo S. Int Immunopharmacol; 2017 Aug 05; 49():142-147. PubMed ID: 28577438 [Abstract] [Full Text] [Related]
6. Schisandrin B suppresses TGFβ1-induced stress fiber formation by inhibiting myosin light chain phosphorylation. Chun JN, Kim SY, Park EJ, Kwon EJ, Bae DJ, Kim IS, Kim HK, Park JK, Lee SW, Park HH, So I, Jeon JH. J Ethnopharmacol; 2014 Mar 14; 152(2):364-71. PubMed ID: 24486209 [Abstract] [Full Text] [Related]
7. Schisandrin B alleviates testicular inflammation and Sertoli cell apoptosis via AR-JNK pathway. Zhang BY, Yang R, Zhu WQ, Zhu CL, Chen LX, Zhao YS, Zhang Y, Wang YQ, Jiang DZ, Tang B, Zhang XM. Sci Rep; 2024 Aug 08; 14(1):18418. PubMed ID: 39117695 [Abstract] [Full Text] [Related]
8. Schisandrin B ameliorated chondrocytes inflammation and osteoarthritis via suppression of NF-κB and MAPK signal pathways. Ran J, Ma C, Xu K, Xu L, He Y, Moqbel SAA, Hu P, Jiang L, Chen W, Bao J, Xiong Y, Wu L. Drug Des Devel Ther; 2018 Aug 08; 12():1195-1204. PubMed ID: 29785089 [Abstract] [Full Text] [Related]
9. [Lycium barbarum polysaccharide promotes M2 polarization of BV2 microglia induced by LPS via inhibiting the TLR4/NF-κB signaling pathway]. Wang Y, Wei W, Guo M, Li S, Chai Z, Ma C, Jiang Y, Song L, Yu J. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2021 Dec 08; 37(12):1066-1072. PubMed ID: 34906293 [Abstract] [Full Text] [Related]
10. Schisandrin B Improves the Renal Function of IgA Nephropathy Rats Through Inhibition of the NF-κB Signalling Pathway. Qin JH, Lin JR, Ding WF, Wu WH. Inflammation; 2019 Jun 08; 42(3):884-894. PubMed ID: 30519926 [Abstract] [Full Text] [Related]
14. Protective effects of Schisandrin B on cigarette smoke-induced airway injury in mice through Nrf2 pathway. Jia R, Zhang H, Yang Z, Zhao H, Liu F, Wang H, Miao M, Wang Q, Liu Y. Int Immunopharmacol; 2017 Dec 08; 53():11-16. PubMed ID: 29031142 [Abstract] [Full Text] [Related]
16. Schisandrin B suppresses TGFβ1 signaling by inhibiting Smad2/3 and MAPK pathways. Park EJ, Chun JN, Kim SH, Kim CY, Lee HJ, Kim HK, Park JK, Lee SW, So I, Jeon JH. Biochem Pharmacol; 2012 Feb 01; 83(3):378-84. PubMed ID: 22100726 [Abstract] [Full Text] [Related]
17. MiR-124 Prevents the Microglial Proinflammatory Response by Inhibiting the Activities of TLR4 and Downstream NLRP3 in Palmitic Acid-Treated BV2 Cells. Yang C, Sui G, Wang L, Chen Z, Wang F. J Mol Neurosci; 2022 Mar 01; 72(3):496-506. PubMed ID: 34652636 [Abstract] [Full Text] [Related]
19. Edaravone dexborneol promotes M2 microglia polarization against lipopolysaccharide-induced inflammation via suppressing TLR4/MyD88/NF-κB pathway. Huang J, Hu X, Li J, Gong D. Naunyn Schmiedebergs Arch Pharmacol; 2024 Sep 01; 397(9):6647-6659. PubMed ID: 38489082 [Abstract] [Full Text] [Related]
20. A Novel 1,8-Naphthyridine-2-Carboxamide Derivative Attenuates Inflammatory Responses and Cell Migration in LPS-Treated BV2 Cells via the Suppression of ROS Generation and TLR4/Myd88/NF-κB Signaling Pathway. Nguyen PL, Bui BP, Lee H, Cho J. Int J Mol Sci; 2021 Mar 03; 22(5):. PubMed ID: 33802409 [Abstract] [Full Text] [Related] Page: [Next] [New Search]